subject: Indian Pharmaceuticals Industry ----aarkstore Enterprise [print this page] The Indian pharmaceutical industry grew at 13% during 2003-2007, driven by rising consumption levels in the country and strong demand from export markets. In 2006-07, the Indian pharma market reached US$ 8.16 billion and is estimated to reach US$ 9.77 billion in 2007-08. At present, Indias pharmaceutical industry constitutes 1-2% of the global pharmaceutical market in value terms.
Key Findings & Highlights
- The market is estimated to register sales of US$ 743 billion in 2008 with a growth of 5-6% compared with 6-7% in 2007.
- In 2007, 71% of oncology product sales came from the US and Europes top five marketsFrance, Germany, Italy, the UK and Spain.
- The growth accelerates in the seven pharmerging markets of China, Brazil, Mexico,
- South Korea, India, Turkey and Russia and is expected to grow by 1213% in 2008 to
US$ 8590 billion.
- Generic producing companies Barr, Ranbaxy, Mylan, Teva, Actavis and Dr Reddys
Labs have become dominant as they keep launching more and more generics.
- In world rankings, the Indian pharmaceutical industry stood fourth in terms of volume
and 13th in terms of value in 2006-07.
- Exports are bifurcated into exports services comprising contract manufacturing,
contract research.
- India currently has more than 80 FDA-approved plants, followed by Italy (55) and
China (27).
Your Questions Answered
- What is the expected growth in the seven pharmerging markets across the world?
- What is the % of product sales came from US & Europes Top five markets?
- What are the primary growth drivers in pharma industry?
- Why companies are increasingly turning to licensing?
- What are the drugs dominated domestic retail pharma market in 2007?
Table of Contents :
Executive summary 11
HIGHLIGHTS 13
1. INDUSTRY OVERVIEW Global and Domestic 18
1.1 Global Pharmaceutical Market 18 1.1.1 Leading Therapeutic Classes 19
1.1.2 Major Markets 21
1.1.3 Trends in Pharmaceutical Industry in 2008 23
1.1.4 Global M&A.25
1.1.5 Major Global Players .28
1.2 Indian Pharmaceutical Industry 31
1.2.1 31
1.2.2 Pharmaceutical Industry Structure 34
1.2.3 Segmentation of the Indian Pharmaceutical Industry.35
1.2.4 Pharmaceutical Market structure and Size.38
1.2.5 Major Therapeutic Segments 43
1.2.6 Merger & Acquisition.44
1.2.7 Demand-Supply Analysis 49
1.2.8 Foreign Direct Investments in Indian Pharma. 49
